发明名称 METHODS FOR PURIFYING TRANS-(-)-DELTA9-TETRAHYDROCANNABINOL AND TRANS-(+)-DELTA9-TETRAHYDROCANNABINOL
摘要 Methods for making trans-(−)-Δ9-tetrahydrocannabinoI and trans-(+)-Δ9-tetrahydrocannabinol are disclosed herein. In one embodiment, a trans-(−)-Δ9-tetrahydrocannabinoI composition is prepared by allowing a composition comprising (±)-Δ9-tetrahydrocannabinol to separate on a chiral stationary phase to provide a trans-(−)-Δ9-tetrahydrocannabinol composition comprising at least about 99% by weight of trans-(−)-Δ9-tetrahydrocannabinol based on the total amount of trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol. The invention also relates to methods for treating or preventing a condition such as pain comprising administering to a patient in need thereof an effective amount of a trans-(−)-Δ9-tetrahydrocannabinol having a purity of at least about 98% based on the total weight of cannabinoids.
申请公布号 US2016184261(A1) 申请公布日期 2016.06.30
申请号 US201615061859 申请日期 2016.03.04
申请人 SVC Pharma LP 发明人 Gutman Arie L.;Etinger Marina;Fedotev Irina;Khanolkar Ram;Nisnevich Gennady A.;Pertsikov Boris;Rukhman Igor;Tishin Boris
分类号 A61K31/352 主分类号 A61K31/352
代理机构 代理人
主权项 1. A composition comprising trans-(−)-Δ9-tetrahydrocannabinol, trans-(+)-Δ9-tetrahydrocannabinol, a water-immiscible organic solvent, a water-miscible alcohol, water, and an alkali metal hydroxide, wherein the trans-(−)-Δ9-tetrahydrocannabinol is present in an amount of from 0.75 molar equivalents to 1.25 molar equivalents per molar equivalent of trans-(+)-Δ9-tetrahydrocannabinol.
地址 Spring Valley NY US